APA (7th ed.) Citation

Sandhu, A., Shen, T., Herrero, P. M., Yuan, C., Qureshi, S., Jiang, X., . . . Dai, Y. Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study. Wiley.

Chicago Style (17th ed.) Citation

Sandhu, Avner, Tong Shen, Paz Martin Herrero, Chao‐Xing Yuan, Samirah Qureshi, Xiaoyu Jiang, Ye Sheng, Christoph Gasteyger, and Yang Dai. Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study. Wiley.

MLA (9th ed.) Citation

Sandhu, Avner, et al. Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1820 (Tarperprumig) in Healthy Adults: Results of a Phase I Study. Wiley.